These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10440459)

  • 1. Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics.
    Caligiuri MP; Lacro JP; Jeste DV
    J Clin Psychopharmacol; 1999 Aug; 19(4):322-8. PubMed ID: 10440459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of neuroleptic-induced parkinsonism in elderly patients with dementia.
    Sweet RA; Pollock BG; Rosen J; Mulsant BH; Altieri LP; Perel JM
    J Geriatr Psychiatry Neurol; 1994; 7(4):251-3. PubMed ID: 7826496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication.
    Caligiuri MP; Rockwell E; Jeste DV
    Am J Geriatr Psychiatry; 1998; 6(1):75-82. PubMed ID: 9469217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients.
    Caligiuri MP; Lohr JB
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):562-7. PubMed ID: 9447497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot study.
    Ganzini L; Heintz R; Hoffman WF; Keepers GA; Casey DE
    J Geriatr Psychiatry Neurol; 1991; 4(4):222-5. PubMed ID: 1686396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to neuroleptic-induced parkinsonism--age and increased substantia nigra echogenicity as putative risk factors.
    Jabs BE; Bartsch AJ; Pfuhlmann B
    Eur Psychiatry; 2003 Jun; 18(4):177-81. PubMed ID: 12814851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the early signs of drug induced parkinsonism.
    Arblaster LA; Lakie M; Mutch WJ; Semple M
    J Neurol Neurosurg Psychiatry; 1993 Mar; 56(3):301-3. PubMed ID: 8096240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of neuroleptic-induced parkinsonism.
    Hassin-Baer S; Sirota P; Korczyn AD; Treves TA; Epstein B; Shabtai H; Martin T; Litvinjuk Y; Giladi N
    J Neural Transm (Vienna); 2001; 108(11):1299-308. PubMed ID: 11768628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
    Marras C; Herrmann N; Anderson GM; Fischer HD; Wang X; Rochon PA
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):381-9. PubMed ID: 23217531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoking and neuroleptic-induced parkinsonism.
    Decina P; Caracci G; Sandik R; Berman W; Mukherjee S; Scapicchio P
    Biol Psychiatry; 1990 Sep; 28(6):502-8. PubMed ID: 1977478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label study.
    Dorfman-Etrog P; Hermesh H; Prilipko L; Weizman A; Munitz H
    Eur Neuropsychopharmacol; 1999 Dec; 9(6):475-7. PubMed ID: 10625114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive therapy in neuroleptic-induced parkinsonism.
    Goswami U; Dutta S; Kuruvilla K; Papp E; Perenyi A
    Biol Psychiatry; 1989 Jul; 26(3):234-8. PubMed ID: 2568133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone.
    Jeste DV; Okamoto A; Napolitano J; Kane JM; Martinez RA
    Am J Psychiatry; 2000 Jul; 157(7):1150-5. PubMed ID: 10873925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Painful sensory symptoms in neuroleptic-induced extrapyramidal syndromes.
    Decina P; Mukherjee S; Caracci G; Harrison K
    Am J Psychiatry; 1992 Aug; 149(8):1075-80. PubMed ID: 1353315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is the glabellar reflex a component of neuroleptic-induced Parkinsonism?].
    Sánchez R; Calvo JM; Jaramillo LE
    Biomedica; 2005 Dec; 25(4):539-46. PubMed ID: 16433181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.
    Munhoz RP; Bertucci Filho D; Teive HA
    Neurol Sci; 2017 Feb; 38(2):319-324. PubMed ID: 27853909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia.
    Caligiuri MP; Lohr JB; Bracha HS; Jeste DV
    Biol Psychiatry; 1991 Jan; 29(2):139-48. PubMed ID: 1671645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetry in clinical features of drug-induced parkinsonism.
    Sethi KD; Zamrini EY
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):64-6. PubMed ID: 1983774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.